Authored by: Dermot Kenny, CEO
In today’s fast-paced pharmaceutical landscape, solving complex challenges requires a deep understanding of both strategy and execution. For nearly two decades, STEM has built a solid foundation of expertise through extensive observations within the sector, and our benchmarking database has become a critical resource in helping clients navigate these complexities.
Our database is more than a collection of numbers; it’s an invaluable source of insights. With over 300 key performance indicators (KPIs) tailored by therapeutic area, life-cycle stage, and geography, it allows clients to measure and compare performance in a highly specialized way. But it’s not just about numbers and metrics—it’s about uncovering the strategic alignment, assessing the precision of messaging, and understanding the beliefs and behaviors of key stakeholders.
What sets STEM apart is the real-world pharmaceutical experience our experts bring to the table. Our team members aren’t just data analysts—they are seasoned professionals who have firsthand experience in commercial teams, overcoming the barriers of bringing new medicines to market, and feeling the pressure to succeed in a highly competitive environment. This experience gives them the ability to interpret data with a level of insight and nuance that others simply can’t match.
This depth of understanding is critical when answering some of the most pressing questions our clients face. Are their strategies consistent across global teams? Is the information being communicated effectively to physicians? Are teams performing effectively. Most importantly, are they identifying and capitalizing on opportunities that can drive real growth? Thanks to our proven methodologies and data-driven insights, our clients often see measurable improvements. In fact, many have experienced double-digit sales growth within just 12 months of working with us.
The value of STEM’s benchmarking database goes beyond just tracking performance. It empowers pharmaceutical companies to make informed decisions, optimize their strategies, and ultimately, achieve success in a competitive and ever-changing market.
Contact us and find out how we can help you accelerate your brand performance.
Jump to a slide with the slide dots.
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read moreWhy Alzheimer’s DMT uptake remains low: Explore key barriers, diagnostic gaps, and market insights from 783 physicians worldwide.
Read moreAgentic AI–powered launch command centers predict pharma launch risks and enable faster, smarter decisions for successful product launches.
Read more